Grow Your Pharma Business Digitally
Market Place
Post Enquiry
Company
01 Gowling WLG (Canada) LLP (8)
Patent
01 2632466 (4)
02 2689663 (4)
Product
01 Ruxolitinib Phosphate (2)
02 Ruxolitinib phosphate (6)
Dosage
01 TABLET (2)
02 Tablet (6)
Exp Date
01 2026-12-12 (4)
02 2028-12-06 (4)